NCT01918865 - Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

February 28, 2015

Conditions

Type 2 Diabetes MellitusObese

Interventions

DRUG

ISIS-PTP1BRx

DRUG

Placebo

DRUG

daily OAD (metformin and/or sulfonylurea)

Trial Locations (21)

1500

Isis Investigational Site, Benoni

7570

Isis Investigational Site, Cape Town

9301

Isis Investigational Site, Bloemfontein

B7600FZN

Isis Investigative Site, Mar del Plata

S2000CVD

Isis Investigative Site, Rosario

T6G 2E1

Isis Investigational Site, Edmonton

V1Y 3G8

Isis Investigational Site, Kelowna

V6J 1S3

Isis Investigational Site, Vancouver

M9R 4E1

Isis Investigational Site, Etobicoke

M4G 3E8

Isis Investigational Site, Toronto

M9V 4B4

Isis Investigative Site, Toronto

S7K 3H3

Isis Investigational Site, Saskatoon

0154

Isis Investigational Site, Centurion

0122

Isis Investigational Site, Mamelodi

0001

Isis Investigational Site, Pretoria

Unknown

Isis Investigational Site, Port Elizabeth

Isis Investigational Site, Durban

Isis Investigational Site, Middelburg

Isis Investigational Site, Cape Town

0184

Isis Investigational Site, Pretoria

0380

Isis Investigational Site, Limpopo